CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[*******]” OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED VERSION OF THIS DOCUMENT HAS ALSO BEEN PROVIDED TO THE SECURITIES...License Agreement • July 1st, 2014 • Fluoropharma Medical, Inc. • In vitro & in vivo diagnostic substances • Massachusetts
Contract Type FiledJuly 1st, 2014 Company Industry JurisdictionThis License Agreement (“Agreement”) is made as of the First day of June 2014 (“Effective Date”), by and between The General Hospital Corporation, d/b/a Massachusetts General Hospital, a not-for-profit Massachusetts corporation, with a principal place of business at 55 Fruit Street, Boston, Massachusetts 02114 (“Hospital”) and FluoroPharma Medical, Inc., a Delaware corporation having a principal place of business at 8 Hillside Avenue, Suite 207, Montclair, New Jersey 07043 (“Company”), each referred to herein individually as a “Party” and collectively as the “Parties.”
CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[*******]” OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED VERSION OF THIS DOCUMENT HAS ALSO BEEN PROVIDED TO THE SECURITIES...License Agreement • July 1st, 2014 • Fluoropharma Medical, Inc. • In vitro & in vivo diagnostic substances • Massachusetts
Contract Type FiledJuly 1st, 2014 Company Industry JurisdictionThis License Agreement (“Agreement”) is made as of the First day of June 2014 (“Effective Date”), by and between The General Hospital Corporation, d/b/a Massachusetts General Hospital, a not-for-profit Massachusetts corporation, with a principal place of business at 55 Fruit Street, Boston, Massachusetts 02114 (“Hospital”) and FluoroPharma Medical, Inc., a Delaware corporation having a principal place of business at 8 Hillside Avenue, Suite 207, Montclair, New Jersey 07043 (“Company”), each referred to herein individually as a “Party” and collectively as the “Parties.”